CD274 and neoplasm: Previous studies have indicated that multiple factors were associated with MPR achievement after NCIO, including peripheral blood inflammatory biomarkers, 18fluorine-fluorodeoxyglucose uptake, PD-L1 expression, tumor mutational burden, and tumor regression rate (37–40).